February 13, 2026 · Form 4 insider transaction
Finn Patrick John bought 712 shares of Twist Bioscience Corporation at $26.66 per share, a transaction worth $19.0K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
The transactions reported on this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 13, 2025.